🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Tobacco Stocks Fall After FDA Announces New Nicotine Regulation Plan

Published 07/28/2017, 01:56 AM
Updated 07/09/2023, 06:31 AM
PM
-
MO
-
VGR
-
BTI
-
GLLA
-

The U.S. Food and Drug Administration announced a plan on Friday to reduce tobacco-related disease and death by increasing regulations on tobacco and nicotine products. The FDA is seeking to lower nicotine levels in cigarettes to non-addictive levels.

In reaction to this news, Tobacco stocks plunged in morning trading. Shares of Altria Group (NYSE:MO) , which makes Marlboro and Parliament brand cigarettes, fell 11% after the announcement. Shares of Gillia (OTC:GLLA) tumbled 7% while British American Tobacco (NYSE:BTI) stock plunged 9%. Meanwhile, Vector Group (NYSE:VGR) shares fell 5% and Philip Morris (NYSE:PM) stock was down 1% in the same time frame.

The FDA’s regulation targets the addictive nature of cigarettes, which could hurt the profitability of tobacco companies. However, the FDA views these regulations as a way to encourage development of innovative tobacco products that may be less dangerous than cigarettes.

“The overwhelming amount of death and disease attributable to tobacco is caused by addiction to cigarettes—the only legal consumer product that, when used as intended, will kill half of all long-term users,” FDA Commissioner Scott Gottlieb said in a statement.

“Envisioning a world where cigarettes would no longer create or sustain addiction, and where adults who still need or want nicotine could get it from alternative and less harmful sources, needs to be the cornerstone of our efforts—and we believe it’s vital that we pursue this common ground.”

The agency also announced plans to delay a policy that requires makers of e-cigarettes, or electronic nicotine delivery systems (ENDS), to get agency approval for their products. To help spur industry innovation, products that were on the market as of August 8th, 2016, do not need to submit applications until 2022.

The agency said it will issue guidance to describe a new enforcement policy “shortly” as it begins a public discussion around lowering nicotine levels. The FDA has not said what level of nicotine it is aiming for.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaries," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>



Altria Group (MO): Free Stock Analysis Report

Philip Morris International Inc (PM): Free Stock Analysis Report

British American Tobacco p.l.c. (BTI): Free Stock Analysis Report

Vector Group Ltd. (VGR): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.